5 Results

People

  1. Chapman
    Chapman
  2. Houghton
    Houghton
  3. Bajorin
    Bajorin
  4. Panageas
    Panageas
  5. Postow
    Postow
  6. Templeton
    Templeton
  7. Wong
    Wong
  8. Ariyan
    Ariyan
  9. Bander
    Bander
  10. Bartlett
    Bartlett

Groups

  1. Department of Medicine (5)
  2. Melanoma and Immunotherapeutics Service (5)
  3. Solid Tumor Oncology Division (5)
  4. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (3)
  5. Immunology Program Faculty (3)
  6. Sloan Kettering Institute Faculty (3)
  7. Biostatistics Service (2)
  8. Center for Hematologic Malignancies (2)
  9. Epidemiology and Biostatistics (2)
  10. GSK Faculty (2)
  1. "article"
  2. "Cancer"
  3. "Melanoma and Immunotherapeutics Service"
Formats
  1. Journal Article (5)
Groups
  1. Department of Medicine (5)
  2. Melanoma and Immunotherapeutics Service (5)
  3. Solid Tumor Oncology Division (5)
  4. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (3)
  5. Immunology Program Faculty (3)
  6. Sloan Kettering Institute Faculty (3)

More Groups

People
  1. Alan Houghton (3)
  2. Paul Chapman (3)
  3. Dean Bajorin (2)
  4. George Wong (2)
  5. Katherine Panageas (2)
  6. Mary Templeton (2)

More People

Years
  1. 2021 (1)
  2. 2020 (1)
  3. 1995 (1)
  4. 1993 (1)
  5. 1991 (1)
Publications
  1. Cancer (5)
Publishers
  1. Wiley Blackwell (5)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Melanoma brain metastasis presentation, treatment, and outcomes in the age of targeted and immunotherapies
    Journal Article

    Bander, E. D.; Yuan, M.; Carnevale, J. A.; Reiner, A. S.; Panageas, K. S.; Postow, M. A.; Tabar, V.; Moss, N. S.
    Cancer (2021)

    Fulltext@MSK | Save
  • High neutrophil-to-lymphocyte ratio (NLR) is associated with treatment failure and death in patients who have melanoma treated with PD-1 inhibitor monotherapy
    Journal Article

    Bartlett, E. K.; Flynn, J. R.; Panageas, K. S.; Ferraro, R. A.; Sta.Cruz, J. M.; Postow, M. A.; Coit, D. G.; Ariyan, C. E.
    Cancer (2020)

    Fulltext@MSK | Save
  • A phase I study of anti‐GD3 ganglioside monoclonal antibody R24 and recombinant human macrophage‐colony stimulating factor in patients with metastatic melanoma
    Journal Article

    Minasian, L. M.; Yao, T. J.; Steffens, T. A.; Scheinberg, D. A.; Williams, L.; Riedel, E.; Houghton, A. N.; Chapman, P. B.
    Cancer (1995)

    Fulltext@MSK | Save
  • Prognostic factors in patients with metastatic malignant melanoma: A multivariate analysis
    Journal Article

    Sirott, M. N.; Bajorin, D. F.; Wong, G. Y. C.; Tao, Y.; Chapman, P. B.; Templeton, M. A.; Houghton, A. N.
    Cancer (1993)

    Fulltext@MSK | Save
  • A phase II trial of high‐dose cisplatin and dacarbazine: Lack of efficacy of high‐dose, cisplatin‐based therapy for metastatic melanoma
    Journal Article

    Steffens, T. A.; Bajorin, D. F.; Chapman, P. B.; Lovett, D. R.; Cody‐Johnson, B. V.; Templeton, M. A.; Heelan, R. T.; Wong, G. Y.; Portlock, C. S.; Oettgen, H. F.; more...
    Cancer (1991)

    Fulltext@MSK | Save